Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease?

Broekman W, Khedoe PPSJ, Schepers K, Roelofs H, Stolk J, Hiemstra PS.

Thorax. 2018 Jun;73(6):565-574. doi: 10.1136/thoraxjnl-2017-210672. Epub 2018 Apr 13.

2.

Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.

Turner AM, Stolk J, Bals R, Lickliter JD, Hamilton J, Christianson DR, Given BD, Burdon JG, Loomba R, Stoller JK, Teckman JH.

J Hepatol. 2018 Mar 21. pii: S0168-8278(18)30176-4. doi: 10.1016/j.jhep.2018.03.012. [Epub ahead of print]

PMID:
29572094
3.

Treatment Effect of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension Quantified by Automatic Comparative Imaging in Computed Tomography Pulmonary Angiography.

Zhai Z, Ota H, Staring M, Stolk J, Sugimura K, Takase K, Stoel BC.

Invest Radiol. 2018 May;53(5):286-292. doi: 10.1097/RLI.0000000000000441.

PMID:
29278545
4.

European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency.

Miravitlles M, Dirksen A, Ferrarotti I, Koblizek V, Lange P, Mahadeva R, McElvaney NG, Parr D, Piitulainen E, Roche N, Stolk J, Thabut G, Turner A, Vogelmeier C, Stockley RA.

Eur Respir J. 2017 Nov 30;50(5). pii: 1700610. doi: 10.1183/13993003.00610-2017. Print 2017 Nov.

PMID:
29191952
5.

Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients' Burden of Disease.

Ghiti Moghadam M, Ten Klooster PM, Vonkeman HE, Kneepkens EL, Klaasen R, Stolk JN, Tchetverikov I, Vreugdenhil SA, van Woerkom JM, Goekoop-Ruiterman YPM, Landewé RBM, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

Arthritis Care Res (Hoboken). 2018 Apr;70(4):516-524. doi: 10.1002/acr.23315.

PMID:
28692770
6.

Lung Density and Pulmonary Artery Diameter are Predictors of Pulmonary Hypertension in Systemic Sclerosis.

Bakker ME, Ninaber MK, Stolk J, Kroft LJM, Schouffoer AA, de Vries Bouwstra JK, van Wijngaarden SE, Stoel BC.

J Thorac Imaging. 2017 Nov;32(6):391-397. doi: 10.1097/RTI.0000000000000279.

PMID:
28549020
7.

Patterns and characterization of COPD exacerbations using real-time data collection.

Ejiofor SI, Stolk J, Fernandez P, Stockley RA.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 25;12:427-434. doi: 10.2147/COPD.S126158. eCollection 2017.

8.

Identification of Novel Short C-Terminal Transcripts of Human SERPINA1 Gene.

Matamala N, Aggarwal N, Iadarola P, Fumagalli M, Gomez-Mariano G, Lara B, Martinez MT, Cuesta I, Stolk J, Janciauskiene S, Martinez-Delgado B.

PLoS One. 2017 Jan 20;12(1):e0170533. doi: 10.1371/journal.pone.0170533. eCollection 2017.

9.

[To reimburse or not? Evaluating expensive drugs differently].

Stolk J.

Ned Tijdschr Geneeskd. 2016;160(0):D1022. Dutch.

PMID:
27879186
10.

Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies.

Ferrarotti I, Corsico AG, Stolk J, Ottaviani S, Fumagalli M, Janciauskiene S, Iadarola P.

COPD. 2017 Feb;14(1):56-65. doi: 10.1080/15412555.2016.1241760. Epub 2016 Nov 9. Review.

PMID:
27827549
11.

Functional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patients.

Broekman W, Roelofs H, Zarcone MC, Taube C, Stolk J, Hiemstra PS.

ERJ Open Res. 2016 Jun 28;2(2). pii: 00045-2015. eCollection 2016 Apr.

12.

1H NMR To Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot Study.

Airoldi C, Ciaramelli C, Fumagalli M, Bussei R, Mazzoni V, Viglio S, Iadarola P, Stolk J.

J Proteome Res. 2016 Dec 2;15(12):4569-4578. Epub 2016 Oct 5.

PMID:
27646345
13.

Clinical development of MUSE cell treatment: The challenges.

Stolk J.

Cell Cycle. 2016 Dec;15(23):3165-3166. Epub 2016 Aug 30. No abstract available.

14.

Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry.

Manders SH, Kievit W, Jansen TL, Stolk JN, Visser H, Schilder AM, Vonkeman HE, Adang E, van de Laar MA, van Riel PL.

J Rheumatol. 2016 Oct;43(10):1787-1794. Epub 2016 Aug 1.

PMID:
27481900
15.

Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation.

Verheul MK, van Erp SJ, van der Woude D, Levarht EW, Mallat MJ, Verspaget HW, Stolk J, Toes RE, van der Meulen-de Jong AE, Hiemstra PS, van Kooten C, Trouw LA.

Ann Rheum Dis. 2016 Aug;75(8):1575-6. doi: 10.1136/annrheumdis-2016-209248. Epub 2016 Apr 29. No abstract available.

PMID:
27130909
16.

Alpha-1 Antitrypsin Regulates Transcriptional Levels of Serine Proteases in Blood Mononuclear Cells.

Aggarwal N, Koepke J, Matamala N, Martinez-Delgado B, Martinez MT, Golpon H, Stolk J, Janciauskiene S, Koczulla R.

Am J Respir Crit Care Med. 2016 May 1;193(9):1065-7. doi: 10.1164/rccm.201510-2062LE. No abstract available.

PMID:
27128707
17.

[Legionella pneumonia after the use of CPAP equipment].

Stolk JM, Russcher A, van Elzakker EP, Schippers EF.

Ned Tijdschr Geneeskd. 2016;160:A9855. Review. Dutch.

PMID:
27096478
18.

A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.

Stolk J, Broekman W, Mauad T, Zwaginga JJ, Roelofs H, Fibbe WE, Oostendorp J, Bajema I, Versteegh MI, Taube C, Hiemstra PS.

QJM. 2016 May;109(5):331-6. doi: 10.1093/qjmed/hcw001. Epub 2016 Jan 27.

19.

Pulmonary Fissure Detection in CT Images Using a Derivative of Stick Filter.

Xiao C, Stoel BC, Bakker ME, Peng Y, Stolk J, Staring M.

IEEE Trans Med Imaging. 2016 Jun;35(6):1488-500. doi: 10.1109/TMI.2016.2517680. Epub 2016 Jan 13.

PMID:
26766371
20.

TNF-α and IL-1β-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor.

Broekman W, Amatngalim GD, de Mooij-Eijk Y, Oostendorp J, Roelofs H, Taube C, Stolk J, Hiemstra PS.

Respir Res. 2016 Jan 11;17:3. doi: 10.1186/s12931-015-0316-1.

21.

Impact of pulmonary fibrosis and elevated pulmonary pressures on right ventricular function in patients with systemic sclerosis.

Yiu KH, Ninaber MK, Kroft LJ, Schouffoer AA, Stolk J, Scherer HU, Meijs J, de Vries-Bouwstra J, Tse HF, Delgado V, Bax JJ, Huizinga TW, Marsan NA.

Rheumatology (Oxford). 2016 Mar;55(3):504-12. doi: 10.1093/rheumatology/kev342. Epub 2015 Oct 15.

PMID:
26472568
22.

Relationship between Change in Lung Density and Long-Term Progression of Lung Function.

Stolk J, Stockley RA, Piitulainen E, Stoel BC.

Am J Respir Crit Care Med. 2015 Jul 1;192(1):114-6. doi: 10.1164/rccm.201502-0370LE. No abstract available.

PMID:
26131993
23.

Association of Lung Inflammatory Cells with Small Airways Function and Exhaled Breath Markers in Smokers - Is There a Specific Role for Mast Cells?

Nussbaumer-Ochsner Y, Stolk J, Ferraz da Silva LF, van Schadewijk A, de Jeu RC, Prins FA, Mauad T, Rabe KF, Hiemstra PS.

PLoS One. 2015 Jun 12;10(6):e0129426. doi: 10.1371/journal.pone.0129426. eCollection 2015.

24.

Conductivity in Exhaled Breath Condensate from Subjects with Emphysema and Type ZZ alpha-1-Antitrypsin Deficiency.

Stolk J, Fumagalli M, Viglio S, Iadarola P.

COPD. 2015 May;12 Suppl 1:32-5. doi: 10.3109/15412555.2015.1021910.

PMID:
25938289
25.

Lung structure and function relation in systemic sclerosis: application of lung densitometry.

Ninaber MK, Stolk J, Smit J, Le Roy EJ, Kroft LJ, Bakker ME, de Vries Bouwstra JK, Schouffoer AA, Staring M, Stoel BC.

Eur J Radiol. 2015 May;84(5):975-9. doi: 10.1016/j.ejrad.2015.01.012. Epub 2015 Jan 22.

PMID:
25650330
26.

Effectiveness of TNF inhibitor treatment with various methotrexate doses in patients with rheumatoid arthritis: results from clinical practice.

Manders SH, Kievit W, Adang E, Jansen TJ, Stolk JN, Visser H, Schilder AM, Vonkeman HE, van de Laar MA, van Riel PL.

Ann Rheum Dis. 2015 Mar;74(3):e24. doi: 10.1136/annrheumdis-2014-207005. Epub 2014 Dec 5. No abstract available.

PMID:
25480886
27.

Function of monocytes and monocyte-derived macrophages in α1-antitrypsin deficiency.

Van't Wout EF, van Schadewijk A, Lomas DA, Stolk J, Marciniak SJ, Hiemstra PS.

Eur Respir J. 2015 Feb;45(2):365-76. doi: 10.1183/09031936.00046114. Epub 2014 Oct 16.

28.

Detection of pulmonary vasculopathy by novel analysis of oxygen uptake in patients with systemic sclerosis: association with pulmonary arterial pressures.

Ninaber MK, Hamersma WB, Schouffoer AA, Kovacs G, Olschewski H, Holman ER, Ajmone Marsan N, Stolk J.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-60-7. Epub 2014 Jul 17.

PMID:
25068203
29.

The global peripheral chemoreflex drive in patients with systemic sclerosis: a rebreathing and exercise study.

Ninaber MK, Hamersma WB, Schouffoer AA, van 't Wout EF, Stolk J.

QJM. 2015 Jan;108(1):33-8. doi: 10.1093/qjmed/hcu150. Epub 2014 Jul 13.

PMID:
25024353
30.

Increased respiratory drive relates to severity of dyspnea in systemic sclerosis.

Ninaber MK, Hamersma WB, Schuerwegh AJ, Stolk J.

BMC Pulm Med. 2014 Apr 4;14:57. doi: 10.1186/1471-2466-14-57.

31.

Towards local progression estimation of pulmonary emphysema using CT.

Staring M, Bakker ME, Stolk J, Shamonin DP, Reiber JH, Stoel BC.

Med Phys. 2014 Feb;41(2):021905. doi: 10.1118/1.4851535.

PMID:
24506626
32.

Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004-2013.

Viglio S, Stolk J, Iadarola P, Giuliano S, Luisetti M, Salvini R, Fumagalli M, Bardoni A.

Proteomes. 2014 Jan 22;2(1):18-52. doi: 10.3390/proteomes2010018. Review.

33.

From micellar electrokinetic chromatography to liquid chromatography-mass spectrometry: revisiting the way of analyzing human fluids for the search of desmosines, putative biomarkers of chronic obstructive pulmonary disease.

Viglio S, Stolk J, Luisetti M, Ferrari F, Piccinini P, Iadarola P.

Electrophoresis. 2014 Jan;35(1):109-18. doi: 10.1002/elps.201300159. Epub 2013 Oct 23. Review.

PMID:
24395662
34.

Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin.

van 't Wout EF, Dickens JA, van Schadewijk A, Haq I, Kwok HF, Ordóñez A, Murphy G, Stolk J, Lomas DA, Hiemstra PS, Marciniak SJ.

Hum Mol Genet. 2014 Feb 15;23(4):929-41. doi: 10.1093/hmg/ddt487. Epub 2013 Oct 4.

35.

Alpha-1 antitrypsin deficiency: the European experience.

Stockley RA, Dirksen A, Stolk J.

COPD. 2013 Mar;10 Suppl 1:50-3. doi: 10.3109/15412555.2013.765838. Review.

PMID:
23527820
36.

Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.

Fumagalli M, Ferrari F, Luisetti M, Stolk J, Hiemstra PS, Capuano D, Viglio S, Fregonese L, Cerveri I, Corana F, Tinelli C, Iadarola P.

Int J Mol Sci. 2012 Oct 29;13(11):13894-910. doi: 10.3390/ijms131113894.

37.

Micellar electrokinetic chromatography with laser induced detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: a comparative analysis.

Ferrari F, Fumagalli M, Piccinini P, Stolk J, Luisetti M, Viglio S, Tinelli C, Iadarola P.

J Chromatogr A. 2012 Nov 30;1266:103-9. doi: 10.1016/j.chroma.2012.10.014. Epub 2012 Oct 13.

PMID:
23116803
38.

[A man who could only sleep sitting].

Schimmel RJ, Stolk J, Versteegh MI, Rommes JH.

Ned Tijdschr Geneeskd. 2012;156(34):A4860. Dutch.

PMID:
22914058
39.

Desmosine, a biomarker for COPD: old and in the way.

Luisetti M, Stolk J, Iadarola P.

Eur Respir J. 2012 Apr;39(4):797-8. doi: 10.1183/09031936.00172911. No abstract available.

40.

Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor.

Stolk J, Stockley RA, Stoel BC, Cooper BG, Piitulainen E, Seersholm N, Chapman KR, Burdon JG, Decramer M, Abboud RT, Mannes GP, Wouters EF, Garrett JE, Barros-Tizon JC, Russi EW, Lomas DA, MacNee WA, Rames A.

Eur Respir J. 2012 Aug;40(2):306-12. doi: 10.1183/09031936.00161911. Epub 2012 Jan 26.

41.

α1-antitrypsin production by proinflammatory and antiinflammatory macrophages and dendritic cells.

van 't Wout EF, van Schadewijk A, Savage ND, Stolk J, Hiemstra PS.

Am J Respir Cell Mol Biol. 2012 May;46(5):607-13. doi: 10.1165/rcmb.2011-0231OC. Epub 2011 Dec 8.

PMID:
22162908
42.

Influence of inspiration level on bronchial lumen measurements with computed tomography.

Bakker ME, Stolk J, Reiber JH, Stoel BC.

Respir Med. 2012 May;106(5):677-86. doi: 10.1016/j.rmed.2011.11.013. Epub 2011 Dec 5.

43.

Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias.

Yiu KH, Schouffoer AA, Marsan NA, Ninaber MK, Stolk J, Vlieland TV, Scherptong RW, Delgado V, Holman ER, Tse HF, Huizinga TW, Bax JJ, Schuerwegh AJ.

Arthritis Rheum. 2011 Dec;63(12):3969-78. doi: 10.1002/art.30614.

44.

A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress.

van Schadewijk A, van't Wout EF, Stolk J, Hiemstra PS.

Cell Stress Chaperones. 2012 Mar;17(2):275-9. doi: 10.1007/s12192-011-0306-2. Epub 2011 Oct 31.

45.

Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.

Fregonese L, Ferrari F, Fumagalli M, Luisetti M, Stolk J, Iadarola P.

COPD. 2011 Oct;8(5):329-33. doi: 10.3109/15412555.2011.589871. Epub 2011 Jul 27.

PMID:
21793711
46.

Lung densitometry to assess progression of emphysema in chronic obstructive pulmonary disease: time to apply in the clinic?

Stolk J, Stoel BC.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1578-80. doi: 10.1164/rccm.201104-0615ED. No abstract available.

PMID:
21693710
47.

Eureka?

Stoel BC, Dirksen A, Stockley RA, Parr D, Piitulainen E, Shaker SB, Russi EW, Bakker ME, Reiber JH, Stolk J.

Radiology. 2011 May;259(2):610-1; author reply 611-2. doi: 10.1148/radiol.11102262. No abstract available.

PMID:
21502395
48.

The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study.

Chappell SL, Daly L, Lotya J, Alsaegh A, Guetta-Baranes T, Roca J, Rabinovich R, Morgan K, Millar AB, Donnelly SC, Keatings V, MacNee W, Stolk J, Hiemstra PS, Miniati M, Monti S, O'Connor CM, Kalsheker N.

BMC Med Genet. 2011 Feb 14;12:24. doi: 10.1186/1471-2350-12-24.

49.

Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis.

Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, van der Giesen FJ, de Jong Z, Stolk J, Voskuyl AE, Scherptong RW, van Laar JM, Schuerwegh AJ, Huizinga TW, Vlieland TP.

Arthritis Care Res (Hoboken). 2011 Jun;63(6):909-17. doi: 10.1002/acr.20448.

50.

A strain energy filter for 3D vessel enhancement with application to pulmonary CT images.

Xiao C, Staring M, Shamonin D, Reiber JH, Stolk J, Stoel BC.

Med Image Anal. 2011 Feb;15(1):112-24. doi: 10.1016/j.media.2010.08.003. Epub 2010 Sep 24.

PMID:
20951629

Supplemental Content

Support Center